311
Views
17
CrossRef citations to date
0
Altmetric
Review

In vitro and in vivo techniques to assess the performance of gastro-retentive drug delivery systems: a review

, MPharm & , MPharm PhD
Pages 951-965 | Published online: 29 Aug 2008

Bibliography

  • Amin A, Shah T, Parikh D, Shah M. Progress in swellable and low density excipients for prolonged gastric retention. Drug Del Tech 2008;8:22-6
  • Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Rel 2000;63:235-59
  • Arora S, Ali JA, Ahuja A, et al. Floating drug delivery systems: a review. AAPS Pharm Sci Tech 2005;6:372-90
  • Talukder R, Fassihi R. Gastroretentive delivery systems: a mini review. Drug Dev Ind Pharm 2004;30:1019-28
  • Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol 2006;6:1-8
  • Chawla G, Gupta P, Koradia V, Bansal AK. Gastroretention: a means to address regional variability in intestinal drug absorption. Pharm Tech 2003;27:50-63
  • Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage forms. J Control Rel 2003;90:143-62
  • Conway BR. Drug delivery strategies for the treatment of helicobacter pylori infections. Curr Pharm Des 2005;11:775-90
  • Hoichman D, Gromova LI, Sela J. Gastroretentive controlled released drugs. Pharm Chem J 2004;38:35-8
  • Waterman KC. A critical review of gastric retentive controlled drug delivery. Pharm Dev Tech 2007;12:1-10
  • Bardonneta PL, Faivrea V, Pugh WJ, et al. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J Control Release 2006;111:1-18
  • Davis SS. Formulation strategies for absorption windows. Drug Dis Today 2005;10:249-57
  • Reddy L, Murthy R. Floating dosage systems in drug delivery. Crit Rev Ther Drug Carrier Syst 2002;19:553-85
  • Kagan L, Hoffman A. Selection of drug candidates for gastroretentive dosage forms: pharmacokinetics following continuous intragastric mode of administration in a rat model. Eur J Pharm Biopharm 2008;69:238-46
  • Berner B, Cowles VE. Case studies in swelling polymeric gastric retentive tablets. Exp Opin Drug Deliv 2006;3:541-8
  • Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Exp Opin Drug Deliv 2006;3:217-33
  • Mathiowitz E, Chickering DE, Lehr CM. Bioadhesive drug delivery systems –fundamentals, novel approaches and development. Volume 98. Marcel Dekker, Inc.
  • Rahman Z, Ali M, Khar RK. Design and evaluation of bilayer floating tablets of Captopril. Acta Pharm 2006;56:49-57
  • Jaimini M, Rana AC, Tanwar YS. Formulation and evaluation of famotidine floating tablets. Curr Drug Deliv 2007;4:51-5
  • Rajinikanth PS, Balasubramaniam J, Mishra B. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of helicobacter pylori. Int J Pharm 2007;335:114-22
  • Rajinikanth PS, Mishra B. Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori. J Control Release 2008;125:33-41
  • Fukuda M, Peppas NA, Mcginity JW. Floating hot-melt extruded tablets for gastroretentive controlled drug release system. J Control Release 2006;115:121-9
  • Streubel A, Siepmann J, Bodmeier R. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur J Pharm Sci 2003;18:37-45
  • Kawashima Y, Niwa T, Takeuchi H, et al. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 1992;81:135-40
  • Satoa Y, Kawashimab Y, Takeuchi H, Yamamotob H. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 2003;55:297-304
  • Satoa Y, Kawashimab Y, Takeuchi H, Yamamotob H. In vitro evaluation of floating and drug releasing behaviours of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 2004;57:235-43
  • Satoa Y, Kawashimab Y, Takeuchi H, Yamamotob H. In vivo evaluation of riboflavin-containing microballoons for floating controlled drug delivery system in healthy human volunteers. J Control Release 2003;93:39-47
  • Sangekar S, Vadino WA, Chaudry I, et al. Evaluation of the effect of food and specific gravity of tablets on gastric retention time. Int J Pharm 1987;35:187-91
  • Rokhade AP, Patil SA, Belhekar AA, et al. Preparation and evaluation of cellulose acetate butyrate and poly(ethylene oxide) blend microspheres for gastroretentive floating delivery of repaglinide. J Appl Poly Sci 2007;105:2764-71
  • Umamaheshwari RB, Jain S, Bhadra D, Jain NK. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. J Pharm Pharmacol 2003;55:1607-13
  • Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J Control Release 2005;107:300-9
  • Jain SK, Agarwal GP, Jain NK. Porous carrier based floating granular delivery system of repaglinide. Drug Dev Ind Pharm 2007;33:1-34
  • Sher P, Ingavle G, Ponrathnamb S, Pawar AP. Low density porous carrier based conceptual drug delivery. Micro Meso Materials 2007;102:290-8
  • Badve SS, Sher P, Korde A, Pawar AP. Development of hollow/porous calcium pectinate beads for floating–pulsatile drug delivery. Eur J Pharm Biopharm 2007;65:85-93
  • Choi BY, Park HJ, Hwang SJ, Park JB. Preparation of alginate beads for floating drug delivery system: effects of CO2 gas-forming agents. Int J Pharm 2002;239:81-91
  • Sher P, Ingavle G, Ponrathnamb S, Pawar AP. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents. Int J Pharm 2007;331:72-83
  • Lee JH, Park TG, Choi HK. Development of oral drug delivery system using floating microspheres. J Microencapsul 1999;16:715-29
  • Soppimath KS, Aminabhavi TM, Agnihotri SA, et al. Effect of coexcipients on drug release and floating property of nifedipine hollow microspheres: a novel gastro-retentive drug delivery system. J Appl Poly Sci 2006;100:486-94
  • Zheng J, Liu C, Bao D, et al. Preparation and evaluation of floating-bioadhesive microparticles containing clarithromycin for the eradication of helicobacter pylori. J Appl Poly Sci 2006;102:2226-32
  • Yang Z, Song B, Li Q, et al. Preparation of microspheres with microballoons inside for floating drug-delivery systems. J Appl Poly Sci 2004;94:197-202
  • El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. Int J Pharm 2002;249:7-21
  • Ichikawa M, Watanabe S, Miyake Y. A new multiple-unit oral floating dosage system. I: preparation and in vitro evaluation of floating and sustained-release characteristics. J Pharm Sci 1991;80:1062-6
  • Shah M. Formulation and optimization of controlled release floating microspheres of Verapamil hydrochloride. Master's thesis. Nirma Univ of Sci & Tech, Gujarat, India; 2008
  • Timmermans J, Moes AJ. How well do floating dosage forms float? Int J Pharm 1990;62:207-16
  • Hamdani J, Moes AJ, Amighi K. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. Int J Pharm 2006;334:35-41
  • Goole J, Vanderbist F, Amighi K. Development and evaluation of new multiple unit levodopa sustained release floating dosage form. Int J Pharm 2007;322:96-103
  • Stops F, Fell JT, Collett JH, Martini LG. Floating dosage forms to prolong gastro-retention – the characterisation of calcium alginate beads. Int J Pharm 2008;350:301-11
  • Dorozynski P, Jachowicz, R, Kulinowski P, et al. The macromolecular polymers for the preparation of hydrodynamically balanced systems – methods of evaluation. Drug Dev Ind Pharm 2004;30:947-57
  • Li S, Lin S, Daggy BP, et al. Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev Ind Pharm 2002;28:783-93
  • Li S, Lin S, Daggy BP, et al. Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int J Pharm 2003;253:13-22
  • Li S, Lin S, Chien YW. Statistical optimization of gastric floating system for oral controlled delivery of calcium [article 1]. AAPS Pharm Sci Tech 2001;2
  • Washington N, Washington C, Wilson CG, Davis SS. What is liquid Graviscon? A comparison of four international formulations. Int J Pharm 1986;34:105-9
  • Hampson FC, Farndale A, Strugala V, et al. Alginate rafts and their characterisation. Int J Pharm 2005;294:137-47
  • Waterhouse ET, Washington C, Washington N. An investigation into the efficacy of the pectin based anti-reflux formulation –Aflurax. Int J Pharm 2000;209:79-85
  • Groning R, Cloera C, Georgarakis M, Muller RS. Compressed collagen sponges as gastroretentive dosage forms: in vitro and in vivo studies. Eur J Pharm Sci 2007;30:1-6
  • Chavanpatil MD, Jain P, Chudhari S, et al. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm 2006;316:86-92
  • Srivastava AK, Wadhwa S, Ridhurkar D, Mishra B. Oral sustained delivery of atenolol from floating matrix tablets –formulation and in vitro evaluation. Drug Dev Ind Pharm 2005;31:367-74
  • Anal AK, Bhopatkar D, Tokura S, et al. Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein. Drug Dev Ind Pharm 2003;29:713-24
  • Patel JK, Patel MM. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres. Curr Drug Deliv 2007;4:41-50
  • Urquhart J, Theeuwes F. Drug delivery system comprising a reservoir containing a plurality of tiny pills. US4434153; 1984
  • Parakh SR, Gothoskar AV, Karad MT. A novel method for the study of water absorption rates by swellable matrices. Pharm Tech 2003;27:40-8
  • Bussemer T, Peppas NA, Bodmeier R. Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur J Pharm Biopharm 2003;56:261-70
  • Klausnera EA, Lavy E, Stepensky D, et al. Novel gastroretentive dosage form: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm Res 2002;19:1516-23
  • Burns SJ, Corness D, Hay G, et al. Development and validation of an in vitro dissolution method for a floating dosage form with biphasic release characteristics. Int J Pharm 1995;121:37-44
  • Durig T, Fassihi R. Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test. J Control Release 2000;67:37-44
  • Pillay V, Fassihi R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J Control Release 1998;55:45-55
  • Karande AD, Yeole PG. Comparative assessment of different dissolution apparatus for floating drug delivery systems. Disso Tech 2006;13:20-23
  • Burns SJ, Attwood D, Barnwell SG. Assessment of a dissolution vessel designed for use with floating and erodible dosage forms. Int J Pharm 1998;160:213-8
  • Nakagawa T, Kondo S, Sasai Y, Kuzuya M. Preparation of floating drug delivery system by plasma technique. Chem Pharm Bull 2006;54:514-8
  • Gohel MC, Mehta PR, Dave RK, Bariya NH. A more relevant dissolution method for evaluation of floating drug delivery system. Disso Tech 2004;11:22-25
  • Gohel MC, Sarvaiya KG. A novel solid dosage form of rifampicin and isoniazid with improved functionality [article 68]. AAPS Pharm Sci Tech 2007;8
  • Bajpai SK, Dubey S. Dynamic release of vitamin B2 from floating barium alginate beads for gastric delivery. J Macro Sci 2007;22:1004-11
  • Parikh RK, Parikh DC, Delvadia RR, Patel SM. A novel multicompartment dissolution apparatus for evaluation of floating dosage form containing poorly soluble weakly basic drug. Disso Tech 2006;13:14-9
  • Ichikawa M, Kato T, Kawahara M, et al. A new multiple-unit oral floating dosage system II: in vivo evaluation of floating and sustained release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs. J Pharm Sci 1991;80:1153-6
  • Machida Y, Inouye K, Tokumura T, et al. Preparation and evaluation of intragastric buoyant preparations. Drug Des Deliv 1989;4:155-61
  • Zou H, Jiang X, Kong L, Gao S. Design and gamma-scintigraphic evaluation of a floating and pulsatile drug delivery system based on an impermeable cylinder. Chem Pharm Bull 2007;55:580-5
  • Satoa Y, Kawashimab Y, Takeuchi H, et al. Pharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. J Control Release 2004;98:75-85
  • Zou H, Jiang X, Kong L, Gao S. Design and evaluation of a dry coated drug delivery system with floating–pulsatile release. J Pharm Sci 2008;97:263-73
  • Chauhan B, Shimpi S, Mahadik KR, Paradkar A. Preparation and evaluation of floating risedronate sodium Gelucire® 39/01 matrices. Acta Pharm 2004;54:205-14
  • Ali J, Arora S, Ahuja A, et al. Formulation and development of hydrodynamically balanced system for metformin: In vitro and in vivo evaluation. Eur J Pharm Biopharm 2007;69:196-201
  • Klausnera EA, Eyal S, Lavy E, et al. Novel levodopa gastroretentive dosage form: in vivo evaluation in dogs. J Control Release 2003;88:117-26
  • Klausnera EA, Eyal S, Barta M, et al. Novel gastroretentive dosage form: evaluation of gastroretentivity and its effect on levodopa absorption in human. Pharm Res 2003;20:1466-73
  • Weitschies W, Koititz R, Cordini D, Trahms L. High resolution of monitoring of the gastrointestinal transit of a magnetically marked capsule. J Pharm Sci 1997;86:1218-22
  • Steingoetter A, Weishaupt D, Kunz P, et al. Magnetic resonance imaging for the in vivo evaluation of gastric-retentive tablets. Pharm Res 2003;20:2001-7
  • Kagan L, Lapidot N, Afargan M, et al. Gastroretentive accordion pill: enhancement of riboflavin bioavailability in humans. J Control Release 2006;113:208-15
  • Shalaby WSW, Blevins WE, Park K. Use of ultrasound imaging and fluoroscopic imaging to study gastric retention of enzyme-digestible hydrogels. Biomaterials 1992;13:289-96
  • Torrado S, Prada P, Torre PM, Torrado S. Chitosan-poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials 2004;25:917-23
  • Torre PM, Torrado G, Torrado1 S. Poly (acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery. J Biomed Mater Res Appl Biomater 2005;72B:191-7
  • Galmiche JP, Delbende B, Perri F, Andriulli A. 13C octanoic acid breath test. Gut 1998;43:S28-30
  • Jonderko AK, Kamińska M, Jonderko K, et al. Short and medium-term reproducibility of gastric emptying of a solid meal determined by a low dose of 13C-octanoic acid and non-dispersive isotope-selective infrared spectrometry. World J Gastroenterol 2006;12:1243-8
  • Dorozynski P, Kulinowski P, Jachowicz R, Jasinski A. Development of a system for simultaneous dissolution studies and magnetic resonance imaging of water transport in hydrodynamically balanced systems: a technical note [article 15]. AAPS Pharm Sci Tech 2007;8
  • Strubing S, Abboud T, Contri RV, et al. New insights on poly(vinyl acetate)-based coated floating tablets: characterisation of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength. Eur J Pharm Biopharm 2008;69:708-17
  • Emami J. In vitro–in vivo correlation: from theory to applications. J Pharm Pharm Sci 2006;9:169-89
  • Souliman S, Beyssac E, Cardot JM, et al. Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system. Drug Dev Ind Pharm 2007;33:1-29
  • He X, Sugawara M, Kobayashi M, et al. An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs. Int J Pharm 2003;263:35-44
  • Kobayashi M, Sada N, Sugawara M, et al. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. Int J Pharm 2001;221:87-94
  • Ginski MJ, Taneja R, Polli JE. Prediction of dissolution–absorption relationships from a continuous dissolution/caco-2 system [article 3]. AAPS Pharm Sci Tech 1999;1
  • Blanquet S, Meunier JP, Minekus M, et al. Recombinant saccharomyces cerevisiae expressing p450 in artificial digestive systems: a model for biodetoxication in the human digestive environment. App Environ Micro 2003;69:2884-92
  • Blanquet S, Zeijdner E, Beyssac E, et al. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm Res 2004;21:585-91
  • Uchida M, Shimizu K. 13C-acetic acid is more sensitive than 13C-octanoic acid for evaluating gastric emptying of liquid enteral nutrient formula by breath test in conscious rats. Biol Pharm Bull 2007;30:487-9
  • Uchida M, Endo N, Shimizu K. Simple and noninvasive breath test using 13C-acetic acid to evaluate gastric emptying in conscious rats and its validation by metoclopramide. J Pharmacol Sci 2005;98:388-95
  • Lee JS, Camilleri M, Zinsmeister AR, et al. A valid, accurate, office-based non-radioactive test for gastric emptying of solids. Gut 2000;46:768-73

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.